Results 211 to 220 of about 1,290,610 (303)
Pharmaceutical governance system for costly drugs through human rights due diligence. [PDF]
Lemmens T +5 more
europepmc +1 more source
How 1st‐Tier Suppliers Respond to Green Public Procurement Policies: An Empirical Analysis
ABSTRACT This article analyses how 1st‐tier suppliers to public organisations respond operationally to Green Public Procurement (GPP) policies. Through a multiple case study of 12 Italian firms operating in different sectors, we develop a classification of suppliers' responses, identifying two interrelated macro‐types: internal operations realignment ...
Antonio Cavallin Toscani, Andrea Vinelli
wiley +1 more source
Analysis of Legislative and Regulatory Frameworks Governing Community Pharmacy in Bulgaria and North Macedonia. [PDF]
Todorova A +4 more
europepmc +1 more source
What Drives CSR Performance: Structures, Declarations or Values?
ABSTRACT Sustainability and corporate social responsibility (CSR) are increasingly central to strategic management, yet a gap persists between formal commitments and actual practice. The study explores the structural and value‐based predictors of the institutional integration of CSR and sustainability, with a focus on the mediating role of the CSR ...
Pavla Vrabcová +3 more
wiley +1 more source
The impact of the United States' distancing from the UN and withholding WHO funding on maternal and child health and nutrition in the Latin America & Caribbean region. [PDF]
Ancira-Moreno M +6 more
europepmc +1 more source
ABSTRACT Digital transformation is increasingly reshaping how social enterprises organize work, engage stakeholders, and pursue social value. While prior research has examined digitalization in hybrid organizations, limited attention has been paid to how responsibility for inclusive digital transformation is enacted internally.
Riccardo Maiolini +2 more
wiley +1 more source
Will the EU AI Act help to mitigate dataset bias in medical AI? [PDF]
Niemiec E, Davis PAE, Hauglid MK.
europepmc +1 more source
ABSTRACT ESG practices offer various benefits for family firms; however, there has been limited focus on how these practices can specifically advantage the owning family. To address this gap, we conduct a multiple‐case study of six Italian family firms.
Rafaela Gjergji +4 more
wiley +1 more source
Medicare advantage becoming a disadvantage with use of artificial intelligence in prior authorization review. [PDF]
Raza S +4 more
europepmc +1 more source

